Skip to content
Screener

Precigen PGEN Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$207M+6.7%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$37.8M+24.8%
Allogene Therapeutics logo
Allogene TherapeuticsALLO
$8.42M+10.3%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$3.14M-21.1%
Regenxbio logo
RegenxbioRGNX
$7.36M-8.6%
Opko Health logo
Opko HealthOPK
$11.01M+11.0%

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$2.59B+404%
Enterprise value$2.68B+431%
P/S97.5×

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The source filing: Precigen’s 10-Q, filed May 13, 2026.

Filed
May 13, 2026, 4:20 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001356090-26-000017
(Amounts in thousands, except share data)March 31,2026December 31,2025
Other accrued liabilities12,48110,993
Indemnification accruals2,476
Deferred revenue410517
Current portion of lease liabilities1,0681,136
Total current liabilities21,10437,306
Long-term debt93,51993,174
Lease liabilities, net of current portion3,6633,980
Other long-term liabilities106134

Item 1. Condensed Consolidated Financial Statements

FAQ

What is Precigen's operating lease liabilities (current)?
Precigen (PGEN) reported operating lease liabilities (current) of $1.07M in Q1 2026.
How has Precigen's operating lease liabilities (current) changed year-over-year?
Precigen's operating lease liabilities (current) increased by 15.1% year-over-year, from $928K to $1.07M.
What is the long-term trend for Precigen's operating lease liabilities (current)?
Over 5 years (2020 to 2025), Precigen's operating lease liabilities (current) has grown at a -15.6% compound annual growth rate (CAGR), from $2.66M to $1.14M.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.

Ask your AI about Precigen's operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude